Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Berkeley Biologics LLC
FDA Inspection
•Berkeley Biologics LLC•September 25, 2023

Berkeley Biologics LLC – FDA Inspection, Sep 25, 2023

Record Details

This FDA Inspection record concerns Berkeley Biologics LLC, with an inspection on September 25, 2023, issued by the Center for Biologics Evaluation and Research, covering biologics.

Company
Berkeley Biologics LLC
Inspection Date
September 25, 2023
Product Type
Biologics
Office
Center for Biologics Evaluation and Research
People
  • Richard L. Bartlett (Issuing Officer)
  • Shelley H. Beausoleil (Issuing Officer)
  • Tania Y. Hall
View Company Profile

ID · 03373494-ad76-49bb-9f0e-95d3f4939f30

Inspection Facts

Official Action Indicated (OAI)

Significant objectionable conditions were found and regulatory or administrative action is recommended.

Inspection number
1218588
FDA center
Biologics
Project area
Human Cellular, Tissue, and Gene Therapies
Outcome
Form 483 issued

FDA Citations

10
  1. 21 CFR 1271.230(a)Validation & approval--established procedures
  2. 21 CFR 1271.75(a)(1)Risk factors, clinical evidence
  3. 21 CFR 1271.47(a)Design of procedures to ensure compliance
  4. 21 CFR 1271.160(b)(4)Training of personnel
  5. 21 CFR 1271.75(d)Donors with risks not determined ineligible
  6. 21 CFR 1271.160(b)(4)Training of personnel
  7. 21 CFR 1271.230(a)Validation & approval--established procedures
  8. 21 CFR 1271.47(a)Design of procedures to ensure compliance
  9. 21 CFR 1271.75(a)(1)Risk factors, clinical evidence
  10. 21 CFR 1271.75(d)Donors with risks not determined ineligible

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Berkeley Biologics LLC

5
DateClassificationOfficeProject area
April 29, 2026Not classifiedSan Francisco District OfficeHuman Cellular, Tissue, and Gene Therapies
June 25, 2021NAICenter for Biologics Evaluation and ResearchHuman Cellular, Tissue, and Gene Therapies
August 28, 2018NAICenter for Biologics Evaluation and ResearchHuman Cellular, Tissue, and Gene Therapies
March 25, 2016NAICenter for Biologics Evaluation and ResearchHuman Cellular, Tissue, and Gene Therapies
February 17, 2012VAICenter for Biologics Evaluation and ResearchHuman Cellular, Tissue, and Gene Therapies
Other documents for Berkeley Biologics LLC
  • FDA Inspection 1314676 - 2026-04-29
  • FDA Inspection 1145973 - 2021-06-25
  • FDA Inspection 1067125 - 2018-08-28
  • FDA Inspection 967555 - 2016-03-25
  • FDA Inspection 765182 - 2012-02-17

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Berkeley Biologics LLC
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.